News | April 07, 2025
Sun Pharma introduces Fexuclue in India for treatment of Erosive Esophagitis
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
Awards highlight Avantor's commitment to the Biopharma industry
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Alkem Medtech to acquire 100% stake of Bombay Ortho
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
The PIPE offering consists of 36,190,476 units
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Amgen India investment totals $200 million through 2025
Subscribe To Our Newsletter & Stay Updated
